Insulet
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
100 Nagog Park, Acton, Massachusetts, 01...Phone Number
(978) 600-7000Website
www.insulet.comRevenue
$2.9 BillionStock Symbol
PODDIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
2
2
1
1
About Insulet
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.Explore more
Insulet Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Insulet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Insulet is spiking on competitors!
Earning: See what the market has to say on Insulet recently announced quarterly report
Funding: Get notified immidiatlly once Insulet has new funding data
Click to see if Insulet had a recent Job posting/layoffs
Check if Insulet has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Insulet
Product Launch: Get notified when Insulet launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Insulet, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Insulet as Masked Content
Find 3 more new buyers
Compare Similar Companies to Insulet
Compare insights from companies similar to Insulet, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$4.8B
10K+
Public
$457.7M
1999
Michael BrownExecutive Vice President & Chief Legal Officer & Chief Compliance Officer
Company Profile Activity
Activity Insights
Insulet is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Insulet is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Insulet.
Insulet financials insights
Gather financial insights about Insulet, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$115.5M
2009
Debt
$60M
Insulet Tech Stack
A closer look at the technologies used by Insulet
Most Recent Scoops
Person-Based
Partnership, Content Marketing
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Collaboration/Web Apps, Employee Engagement, HR Operations, Organizational Development
Open Position
Insulet News & Media
INSULET CORPORATION (PODD) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Insulet Corporation Investors of Upcoming Deadline
Insulet Shareholders Between February 21, 2025 and May 25, 2026 - Contact Bernstein Liebhard For More Information Regarding LawsuitDeadline Alert: Insulet Corporation (PODD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 31, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) securities between February 21, 2025 and May 26, 2026 inclusive (the “Class Period”).INSULET DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Insulet Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 31 Deadline in Securities Class Action – PODD
NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”), of the important August 31, 2026 lead plaintiff deadline.Portnoy Law Firm Announces Class Action on Behalf of Insulet Corporation Investors
LOS ANGELES, Aug. 19, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Insulet Corporation, (“Insulet” or the "Company") (NASDAQ: PODD) investors of a class action on behalf of investors that bought securities between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”). Insulet investors have until August 31, 2026 to file a lead plaintiff motion.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Insulet
Sign Up For FreeTo access detailed company insights
Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple,... Read More
